Hyderabad: NATCO Pharma Limited, an Indian pharmaceutical company, has announced the approval of its Abbreviated New Drug ...

SIGN UP TO CONTINUEPrint Subscriber? Sign Up for Full Access!Please sign up for as low as 36 cents per day to continue ...

Chip maker AMD (AMD) is falling 6.5% today after a Chinese startup, DeepSeek, reportedly developed top-notch AI models using ...

If you're considering buying a foldable phone like the Google Pixel 9 Pro Fold or Samsung Galaxy Z Fold 6, it's probably for ...

The world’s oldest map unlocks secrets from 3,000 years ago revealing how our ancestors understood the world. The Babylonian ...

The approval is for the Abbreviated New Drug Application (ANDA) for Everolimus tablets for oral suspension (TFOS) of ...

The VTronix Digital Drawing Tablet for children has been urgently recalled by Coles supermarkets across Australia. The toys ...

Natco Pharma announced approval of its ANDA for Everolimus tablets for oral suspension (TFOS), 2mg, 3mg and 5mg, a generic version of AFINITOR DISPERZ by Novartis Pharmaceutical Corporation. NATCO's ...

CIBC analyst Todd Coupland maintained a Buy rating on Shopify (SHOP – Research Report) today and set a price target of $135.00. The company’s ...

NATCO Pharma said that it has received approval of its ANDA for Everolimus tablets for oral suspension (TFOS), a generic version of AFINITOR DISPERZ by Novartis Pharmaceutical Corporation.

In a report released yesterday, Michael Turrin from Wells Fargo maintained a Buy rating on Microsoft (MSFT – Research Report), with a price ...

Google is clearly fed up with developers who ignore adaptability when designing their apps. The tech giant is currently working on Android 16, an operating system ...